BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021) BMC Cancer Lee, Y Y D, Nguyen, D T, Moodie, T, O’Brien, R, McMaster, A, Hickey, A, Pritchard, N, Poulsen, P, Tabaksblat, E M, Weber, B, Worm, E, Pryor, D, Chu, J, Hardcastle, N, Booth, J, Gebski, V, Wang, T & Keall, P 2021, ' Study protocol of the LARK (TROG 17.03) clinical trial : a phase II trial investigating the dosimetric impact of Liver Ablative Radiotherapy using Kilovoltage intrafraction monitoring ', BMC Cancer, vol. 21, no. 1, 494 . https://doi.org/10.1186/s12885-021-08184-x